Bellevue Life Sciences-WRNTOSRHWPreferred / convertible
13F holders, Q1 2025 (March 31)20holders
2famous investors
$0.23avg. 13F price*
At the end of Q1 2025, 20 institutions reported holding Bellevue Life Sciences-WRNT (OSRHW) in their 13F filings. The largest holders were Boothbay Fund Management, LLC ($585K), Periscope Capital Inc. ($16K) and Polar Asset Management Partners Inc. ($14K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bellevue Life Sciences-WRNT
- Filed as
- OSR HLDGS INC (Q1 2025)
- CUSIP
- 68840D110
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $689K |
| Exits | 0 | $0 |
Ownership 20 holders
| Boothbay Fund Management, LLC | — | New | 311,040 | $585K |
| Periscope Capital Inc. | — | New | 408,900 | $16K |
| Polar Asset Management Partners Inc. | — | New | 360,000 | $14K |
| Atw Spac Management LLC | — | New | 311,040 | $12K |
| Clear Street LLC | — | New | 292,483 | $11K |
| Saba Capital Management, L.P. | — | New | 250,000 | $10K |
| Rivernorth Capital Management, LLC | — | New | 250,000 | $10K |
| D. E. Shaw & Co. | — | New | 150,000 | $6K |
| Shaolin Capital Management LLC | — | New | 157,800 | $6K |
| Wolverine Asset Management LLC | — | New | 118,994 | $5K |
| Centiva Capital, LP | — | New | 100,000 | $4K |
| Mint Tower Capital Management B.V. | — | New | 75,000 | $3K |
| Aristeia Capital, L.L.C. | — | New | 73,341 | $3K |
| Two Sigma Securities, LLC | — | New | 31,018 | $1K |
| Heights Capital Management, Inc. | — | New | 28,279 | $1K |
| Gabelli Funds LLC | — | New | 27,050 | $1K |
| Flow Traders U.S. LLC | — | New | 23,251 | $1K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | New | 20,800 | $790 |
| Citadel Advisors | — | New | 12,620 | $505 |
| UBS Group AG | — | New | 2,468 | $94 |
"% of holder's portfolio" is OSRHW's weight in each manager's 13F, not the share of Bellevue Life Sciences-WRNT the manager owns.